The week in industry: New Drug Discovery Advisory Network established
Vertex Pharmaceuticals and Semma Therapeutics (both MA, USA) join to produce novel diabetes treatment, Processa Pharmaceuticals (MD, USA) to develop anti-fibrotic and muscular regeneration drug, breakthrough designation given to respiratory syncytial virus vaccine.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>